世界の敗血症治療薬市場は現在、2023年に約31億7,000万米ドルと評価されており、2024年から2032年の予測期間にわたって6.18%のCAGRで成長すると予測されています。
敗血症は、感染に対する体の反応から生じる生命を脅かす医療上の緊急事態であり、引き続き世界的な医療上の差し迫った課題となっています。細菌感染症の発生率の上昇、抗菌薬耐性、重篤な感染症にかかりやすい高齢者人口の増加により、市場では効果的な敗血症治療ソリューションに対する需要が急増しています。標的療法における新たな進歩と革新的な医薬品開発は、市場の状況を大きく形成しています。さらに、政府支援の取り組みや抗生物質の研究開発への投資により、世界中で増加する敗血症関連死亡率を抑制することを目的として、敗血症治療分野の拡大が推進されています。
院内感染（HAI）や多剤耐性病原体の有病率の上昇により、新しく効果の高い治療選択肢の必要性が高まっています。世界保健機関（WHO）が敗血症を死亡の主な原因として報告していることを受けて、医療提供者はこの病気の影響を軽減するための迅速な介入戦略にますます重点を置いています。さらに、製薬会社は抗菌管理プログラムに戦略的投資を行っており、薬剤耐性の発現を最小限に抑えるために最適な薬剤使用を確保しています。業界の主要企業は研究機関と積極的に協力して次世代の抗生物質や補助療法を開発し、患者の転帰を改善しています。
北アメリカは、主に確立された医療インフラ、高い意識レベル、抗生物質発見への多額の研究開発投資により、敗血症治療薬市場を支配しています。アメリカは敗血症関連の入院患者の増加と感染症研究への政府資金提供により最大の市場シェアを占めている。一方、ヨーロッパは欧州抗菌薬耐性（AMR）行動計画（European Antimicrobial Resistance (AMR) Action Plan）などの取り組みに支えられ、緊密に追随しています。アジア太平洋地域は、予測期間中に最も急速な成長率を示すと予想されており、中国やインドなどの国では、医療施設の拡大や高度な治療選択肢へのアクセスの改善により、敗血症患者の負担が増大しています。ラテンアメリカ、中東、アフリカでも、政府が医療インフラや感染症管理プログラムの改善に投資しているため、大きな市場機会が存在します。
目次
Table of Contents
Chapter 1. Global Sepsis Therapeutics Market Executive Summary
1.1. Global Sepsis Therapeutics Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Drug Class
1.3.2. By Route of Administration
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Sepsis Therapeutics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Sepsis Therapeutics Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Sepsis and Related Mortality Rates
3.1.2. Advancements in Antimicrobial Stewardship Programs
3.1.3. Government Investments in Antibiotic R&D
3.2. Market Challenges
3.2.1. High Cost of Advanced Therapeutics
3.2.2. Complexity in Developing Multi-Drug Resistant Pathogen Treatments
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Development of Next-Generation Antibiotics
3.3.3. Strategic Collaborations and Partnerships
Chapter 4. Global Sepsis Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Sepsis Therapeutics Market Size & Forecasts by Drug Class 2022-2032
5.1. Segment Dashboard
5.2. Global Sepsis Therapeutics Market: Drug Class Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Cephalosporin
5.2.2. Glycopeptide
5.2.3. Aminoglycosides
Chapter 6. Global Sepsis Therapeutics Market Size & Forecasts by Route of Administration 2022-2032
6.1. Segment Dashboard
6.2. Global Sepsis Therapeutics Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Parenteral
6.2.2. Oral
Chapter 7. Global Sepsis Therapeutics Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. Global Sepsis Therapeutics Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Global Sepsis Therapeutics Market Size & Forecasts by Region 2022-2032
8.1. North America Sepsis Therapeutics Market
8.1.1. U.S. Sepsis Therapeutics Market
8.1.1.1. Cephalosporin Breakdown Size & Forecasts, 2022-2032
8.1.1.2. Glycopeptide Breakdown Size & Forecasts, 2022-2032
8.1.1.3. Aminoglycosides Breakdown Size & Forecasts, 2022-2032
8.1.1.4. Parenteral Breakdown Size & Forecasts, 2022-2032
8.1.1.5. Oral Breakdown Size & Forecasts, 2022-2032
8.1.1.6. Hospital Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.1.7. Retail Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.1.8. Online Pharmacies Breakdown Size & Forecasts, 2022-2032
8.1.2. Canada Sepsis Therapeutics Market
8.2. Europe Sepsis Therapeutics Market
8.2.1. U.K. Sepsis Therapeutics Market
8.2.2. Germany Sepsis Therapeutics Market
8.2.3. France Sepsis Therapeutics Market
8.2.4. Spain Sepsis Therapeutics Market
8.2.5. Italy Sepsis Therapeutics Market
8.2.6. Rest of Europe Sepsis Therapeutics Market
8.3. Asia-Pacific Sepsis Therapeutics Market
8.3.1. China Sepsis Therapeutics Market
8.3.2. India Sepsis Therapeutics Market
8.3.3. Japan Sepsis Therapeutics Market
8.3.4. Australia Sepsis Therapeutics Market
8.3.5. South Korea Sepsis Therapeutics Market
8.3.6. Rest of Asia Pacific Sepsis Therapeutics Market
8.4. Latin America Sepsis Therapeutics Market
8.4.1. Brazil Sepsis Therapeutics Market
8.4.2. Mexico Sepsis Therapeutics Market
8.4.3. Rest of Latin America Sepsis Therapeutics Market
8.5. Middle East & Africa Sepsis Therapeutics Market
8.5.1. Saudi Arabia Sepsis Therapeutics Market
8.5.2. South Africa Sepsis Therapeutics Market
8.5.3. Rest of Middle East & Africa Sepsis Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Pfizer Inc.
9.1.2. Merck & Co., Inc.
9.1.3. Novartis AG
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. GlaxoSmithKline plc
9.3.3. AstraZeneca plc
9.3.4. Bayer AG
9.3.5. F. Hoffmann-La Roche Ltd
9.3.6. Sanofi S.A.
9.3.7. Eli Lilly and Company
9.3.8. Johnson & Johnson
9.3.9. Astellas Pharma Inc.
9.3.10. Bristol-Myers Squibb Company
9.3.11. Abbott Laboratories
9.3.12. Mylan N.V.
9.3.13. Baxter International Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Sepsis Therapeutics Market, Report Scope
TABLE 2. Global Sepsis Therapeutics Market Estimates & Forecasts by Region 2022-2032 (USD Million/Billion)
TABLE 3. Global Sepsis Therapeutics Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
TABLE 4. Global Sepsis Therapeutics Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Million/Billion)
TABLE 5. Global Sepsis Therapeutics Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Million/Billion)
TABLE 6. Global Sepsis Therapeutics Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 7. Global Sepsis Therapeutics Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 8. Global Sepsis Therapeutics Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 9. Global Sepsis Therapeutics Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 10. Global Sepsis Therapeutics Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 11. Global Sepsis Therapeutics Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 12. Global Sepsis Therapeutics Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 13. Global Sepsis Therapeutics Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 14. Global Sepsis Therapeutics Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 15. U.S. Sepsis Therapeutics Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 16. U.S. Sepsis Therapeutics Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
TABLE 17. U.S. Sepsis Therapeutics Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Million/Billion)
TABLE 18. Canada Sepsis Therapeutics Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 19. Canada Sepsis Therapeutics Market Estimates & Forecasts by Drug Class 2022-2032 (USD Million/Billion)
TABLE 20. Canada Sepsis Therapeutics Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Million/Billion)
….. This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Sepsis Therapeutics Market, Research Methodology
FIG 2. Global Sepsis Therapeutics Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Sepsis Therapeutics Market, Key Trends 2023
FIG 5. Global Sepsis Therapeutics Market, Growth Prospects 2022-2032
FIG 6. Global Sepsis Therapeutics Market, Porter’s 5 Force Model
FIG 7. Global Sepsis Therapeutics Market, PESTEL Analysis
FIG 8. Global Sepsis Therapeutics Market, Value Chain Analysis
FIG 9. Global Sepsis Therapeutics Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 10. Global Sepsis Therapeutics Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 11. Global Sepsis Therapeutics Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 12. Global Sepsis Therapeutics Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 13. Global Sepsis Therapeutics Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 14. Global Sepsis Therapeutics Market, Regional Snapshot 2022 & 2032
FIG 15. North America Sepsis Therapeutics Market 2022 & 2032 (USD Million/Billion)
FIG 16. Europe Sepsis Therapeutics Market 2022 & 2032 (USD Million/Billion)
FIG 17. Asia Pacific Sepsis Therapeutics Market 2022 & 2032 (USD Million/Billion)
FIG 18. Latin America Sepsis Therapeutics Market 2022 & 2032 (USD Million/Billion)
FIG 19. Middle East & Africa Sepsis Therapeutics Market 2022 & 2032 (USD Million/Billion)
FIG 20. Global Sepsis Therapeutics Market, Company Market Share Analysis (2023)
….. This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
